<DOC>
	<DOCNO>NCT00483886</DOCNO>
	<brief_summary>The purpose study determine whether prucalopride safe effective treatment chronic constipation . Hypothesis : Prucalopride 2 mg 4 mg give daily 12 week superior placebo treatment patient chronic constipation well tolerated patient .</brief_summary>
	<brief_title>Efficacy Safety Study Prucalopride Treatment Chronic Constipation</brief_title>
	<detailed_description>This multicentre , Phase III trial parallel-group design , consist 2 week drug-free run-in period , follow 12-week , double-blind , placebo-controlled treatment period . During run-in period , subject 's bowel habit document existence constipation confirm . At start period , exist laxative medication withdrawn subject instruct change diet lifestyle trial . Subjects allowed take laxative ( Dulcolax ) rescue medication throughout trial , bowel movement three consecutive day . No Dulcolax enemas take within 48 hour prior start double-blind treatment 48 hour follow start double-blind treatment . Subjects enter double-blind period constipation show present run-in period . If definition constipation meet 2-week run-in , subject consider ineligible double-blind period discontinue study . During double-blind , randomise , placebo-controlled period , subject treat 12 week either 2 mg 4 mg R108512 placebo , give daily breakfast .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>1 . Male nonpregnant , non breastfeed female outpatient least 18 year age ( upper age limit ) . 2 . History constipation ; subject report , average , two few spontaneous bowel movement per week result feel complete evacuation one follow least 6 month selection visit : 1. hard ( little ball ) and/or hard stool least quarter stool 2. sensation incomplete evacuation follow least quarter stool 3. strain defecation least quarter time . The criterion applicable spontaneous bowel movement , i.e. , precede within period 24 hour intake laxative agent use enema . Subjects never spontaneous bowel movement consider constipate eligible trial . 1 . Subjects constipation think druginduced , subject use disallowed medication . 2 . Subjects suffer endocrine disorder , metabolic disorder neurologic disorder . 3 . Subjects megacolon/megarectum diagnosis pseudoobstruction . 4 . Constipation result surgery . 5 . Known suspected organic disorder large bowel , i.e . obstruction , carcinoma , inflammatory bowel disease . 6 . Subjects severe clinically uncontrolled cardiovascular , liver , lung disease , neurologic psychiatric disorder ( include active alcohol drug abuse ) , cancer AIDS , gastrointestinal endocrine disorder . 7 . Subjects impaired renal function . 8 . Subjects clinically significant abnormality haematology , urinalysis , blood chemistry . 9 . Females childbearing potential without adequate contraceptive protection trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>constipation</keyword>
	<keyword>prucalopride</keyword>
	<keyword>QOL</keyword>
	<keyword>SCBM</keyword>
	<keyword>PAC-SYM</keyword>
</DOC>